Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Oral Herpes Simplex

In brief

The purpose of this study is to determine if a new treatment is effective for the treatment of recurrent symptomatic oral herpes virus infections.

Key facts

Study ID

NCT01308424

Run by

Beech Tree Labs, Inc.

People needed

171

Starts

2011-01-01

Expected to finish

2012-11-01

Last updated by the study team

2013-08-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical history of recurrent cold sores averaging 2 or more episodes per year
• Experiences prodromal symptoms (tingling, burning, itching) of cold sores
• Herpes Simplex Virus seropositive (by blood test)

You may not qualify if…

• Immuno-suppressed or taking immunosuppressant medication
• Use of antiviral therapy directly prior and during the study

Where it is running

• University of Kentucky College of Dentistry/Center for Oral Health Research — Lexington, Kentucky, United States
• School of Dental Medicine, University at Buffalo — Buffalo, New York, United States
• Family Dentistry — Norwich, New York, United States
• University of Pittsburgh School of Dental Medicine — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.